LRP5 and osteosarcoma: LRP5 was found to be overexpressed and correlated with tumor metastasis in high-grade osteosarcoma; blocking the LRP5 by its dominant negative form decreased tumorigenicity and metastasis of osteosarcoma [38], [39].